ARCHIVES

CMS Considering Regulatory Standards for Drug Company Bundling of Products.

This article is from The Cancer Letter archive.

Vol. 32 No. 37 | October 20, 2006

Download PDF Visit The Full Archive

Related Articles

Cancer Meetings Listed

October 24, 1997

NCI Details How Year 2000 Goals Can Be Reached Bypass Budget Spells Out How Much It Will Cost

June 8, 1984

New P01 Guidelines Will Go Into Effect Feb. 1 Not Oct. 1

September 16, 1983

Contracts Awarded For $30 Million Heavy Smokers Clinical Trials

October 10, 1986

Boyd Steps Down As DTP Director, Returns to Research

February 16, 1990

NCI to Ask Cancer Panel, NCAB, to Help Respond To Request for Review Of National Cancer Program

December 4, 1992